Release  date:  08/19/24 
	Renewal   date:   10/15/24 
  Expiration  date: 08/18/26 
Estimated Time of Completion:  1 hour  
Education was updated and renewed to reflect the CDC’s updated RSV guidelines.
		Description
        				In the Addressing the Impact of RSV and Vaccine Hesitancy educational series, we explore the efficacy of RSV vaccines and discuss preventive strategies aimed at reducing the occurrence of severe RSV respiratory illness in infants, children, and older adults. Participate in case-based reviews of RSV management strategies and engage in decision-point knowledge checks.
			  
	
		
Learning Objectives
	
    
	
	
    
  - Discuss signs and  symptoms of RSV infection.
- Describe the  epidemiology of RSV infection.
- Outline diagnostic  testing of persons with possible RSV infection.
 
	 
 
	
		
Target Audience
	
	
	
		Geriatricians, infection disease physicians, intensivists, nurse practitioners, nurses, obstetricians/gynecologists, pediatricians, pharmacists, physician assistants, primary care physicians, pulmonologists, and other prescribing and non-prescribing providers
 
	 
 
	
		
Accreditation
	
	
	
  In support of improving patient care,  Cleveland Clinic Center for Continuing Education is jointly accredited by the  Accreditation Council for Continuing Medical Education (ACCME), the  Accreditation Council for Pharmacy Education (ACPE), and the American Nurses  Credentialing Center (ANCC), to provide continuing education for the healthcare  team. 
 
Physicians / American  Medical Association (AMA)
Cleveland Clinic Center for Continuing Education designates this internet  enduring activity for a maximum of 1.0 AMA PRA  Category 1 Credits™. Physicians should claim  only the credit commensurate with the extent of their participation in the  activity. 
Participants  claiming CME credit from this activity may submit the credit hours to the  American Osteopathic Association for Category 2 credit. 
Nurses /  American Nurses Credentialing Center (ANCC)
  Cleveland Clinic Center for Continuing Education designates this internet enduring  activity for a maximum of 1.0 ANCC contact hours. 
Physician Assistants / American Academy of PAs (AAPA)
  Cleveland Clinic Center for Continuing Education has been authorized by the  American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for  activities planned in accordance with AAPA CME Criteria. This activity is  designated for 1.0 AAPA Category 1 CME credits. PAs should only  claim credit commensurate with the extent of their participation.
Pharmacists/Accreditation  Council of Pharmacy Education (ACPE)
  Cleveland Clinic Center for Continuing  Education designates this knowledge-based activity for a maximum of 1.0 hours. Credit will be provided to NABP CPE Monitor  within 60 days after the activity completion.  
Universal Activity Number List: Pharmacist UAN: JA0000192-0000-24-576-H06-P
Certificate  of Participation 
A  certificate of participation will be provided to other health care  professionals for requesting credits in accordance with their professional  boards and/or associations. 
         
	 
 
                
              
	
		
Faculty
	
	
	
Cleveland  Clinic Planning Committee  
  
Cecile Foshee, PhD
  Co-Activity Director
  Director, Office of Interprofessional Learning
Steven Gordon,  MD
  Co-Activity Director
Chairman, Infectious Disease Department 
Kaitlyn  Rivard, PharmD
  Co-Activity Director
  Department of Pharmacy  
 
Nichole Brown,  MSN, RN, CHSE-A, PhD(c )
  Nursing Institute 
Neal Chaisson,  MD
  Department of Critical Care Medicine
Department of Pulmonary Medicine  
Frank Esper,  MD
  Pediatric Infectious Disease
Cleveland Clinic Children’s Hospital  
Debra  Kangisser, PA-C
  Director of Education
Physician Assistant Services 
Aanchal  Kapoor, MD, Med
  Department of Critical Care Medicine
Department of Pulmonary Medicine 
Steven  Kawczak, PhD, CHCP, FACEHP
Co-Medical Director, Center for Continuing Education 
Neil Mehta,  MBBS, MS
  Center for Technology-Enhanced
  Knowledge and Instruction
  Associate Dean of Curricular Affairs, Cleveland Clinic Lerner College of
Medicine 
Anne  Vanderbilt, APRN
  Senior Director, Advance Nursing Practices
Center for Geriatric Medicine 
Hannah Wang,  MD
  Director, Molecular Microbiology & Virology 
Faculty 
  
Susan J. Rehm, MD, FIDSA, FACP
Professor of Medicine, Cleveland Clinic Lerner College of Medicine
Vice Chair of Infectious Disease
Executive Director of Physician Health
Cleveland Clinic
Cleveland, OH
    
        
	 
	 
 
	
		
CME Disclaimer
	
	
	
    	The information in this educational activity is provided for  general medical education purposes only and is not meant to substitute for the  independent medical judgment of a physician relative to diagnostic and  treatment options of a specific patient’s medical condition. The viewpoints expressed  in this CME activity are those of the authors/faculty. They do not represent an  endorsement by The Cleveland Clinic Foundation. In no event will The Cleveland  Clinic Foundation be liable for any decision made or action taken in reliance  upon the information provided through this CME activity.
 
	 
 
Disclosures
	In accordance with the Standards for Integrity and Independence issued by the Accreditation Council for Continuing Medical Education (ACCME), Cleveland Clinic Center for Continuing Education mitigates all relevant conflicts of interest to ensure CME activities are free of commercial bias.
The following faculty have indicated that they may have a relationship, which in the context of their presentation(s), could be perceived as a potential conflict of interest:
			  
 
 
      
        | Neal    Chaisson, MD |  | 
      
        | Merck | Teaching      and Speaking | 
      
        | United      Therapeutics Corporation | ConsultingTeaching and Speaking
 | 
      
        | Bayer | Advisor      or review panel participantTeaching and Speaking
 | 
    
 
 
		
    
      
        | Frank    Esper, MD |  | 
      
        | Procter      & Gamble | Advisor      or review panel participant | 
    
 
 
      
        | Susan Rehm, MD |  | 
      
        | Amgen, Eli Lilly, Merck, Pfizer | Ownership interest (stock, stock options in a publicly owned company) | 
    
		
		
				
				
      
        | Kaitlyn Rivard, PharmD |  | 
      
        | Pfizer, Inc. | Advisor or review panel participant | 
    
 
 
 
    
      
        | Hannah    Wang, MD |  | 
      
        | Cepheid | Research:      Research: Cepheid may be providing reagents and financial support for a      study on which I am principal investigator. The contract is currently under      negotiation. | 
      
        | Hologic | Research:      Research: Hologic is providing reagents for a study in which I am a      co-investigator. | 
    
	  
 
				
				
				
The following faculty have indicated they have no relationship which, in the context of their presentation(s), could be perceived as a potential conflict of interest:
Nichole  Brown, MSN, BSN 
  Cecile  M Foshee, PhD
  Steven  Mark Gordon, MD
  Debra  Kangisser, PA-C
  Aanchal  Kapoor, MD
  Steven  Kawczak, PhD
  Neil  Mehta, MD
  Anne  Vanderbilt, APRN 
  
	Acknowledgment
The Cleveland Clinic Center for Continuing Education acknowledges an educational grant for support of this activity from ModernaTX, Inc.
  
 
This CME activity was produced by the Cleveland Clinic’s Education Institute.